Krust B, Callebaut C, Hovanessian A G
Unité de Virologie et Immunologie Cellulaire, Unité 1157 CNRS, Institut Pasteur, Paris, France.
AIDS Res Hum Retroviruses. 1993 Nov;9(11):1087-90. doi: 10.1089/aid.1993.9.1087.
Polyadenylic-polyuridylic acid referred to as poly(A).poly(U), is a synthetic double-stranded RNA that has been shown to manifest both antitumoral and immunodulatory activities. Previously, we have reported that poly(A).poly(U) inhibits HIV infection in cell cultures. Here we provide direct evidence to demonstrate that the inhibitory action of poly(A).poly(U) is through its capacity to prevent entry of HIV particles into CD4-positive T lymphocytes. Such inhibition of HIV entry is also observed in the case of other polyanions such as heparin, dextran sulfate, and poly(I).poly(C). The mechanism of inhibition appears to occur postbinding of HIV particles to the CD4 receptor molecules, because the binding of the external envelope glycoprotein of HIV-1 (gp120) is not affected significantly in the presence of poly(A).poly(U) or other polyanions. These results confirm the potential of poly(A).poly(U) as an antiviral drug against HIV infection.
聚腺苷酸-聚尿苷酸,简称为聚(A)·聚(U),是一种合成双链RNA,已被证明具有抗肿瘤和免疫调节活性。此前,我们曾报道聚(A)·聚(U)在细胞培养中可抑制HIV感染。在此,我们提供直接证据证明聚(A)·聚(U)的抑制作用是通过其阻止HIV颗粒进入CD4阳性T淋巴细胞的能力实现的。在其他聚阴离子如肝素、硫酸葡聚糖和聚(I)·聚(C)的情况下,也观察到了对HIV进入的这种抑制作用。抑制机制似乎发生在HIV颗粒与CD4受体分子结合之后,因为在聚(A)·聚(U)或其他聚阴离子存在的情况下,HIV-1外膜糖蛋白(gp120)的结合并未受到显著影响。这些结果证实了聚(A)·聚(U)作为抗HIV感染抗病毒药物的潜力。